Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea

In South Korea, the National Immunization Program offers a 23-valent pneumococcal polysaccharide vaccine (PPSV23) for the elderly; however, the 13-valent pneumococcal conjugate vaccine (PCV13) is not included, and vaccination is not offered to younger, at-risk populations. This study offers a compar...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Hum Vaccin Immunother
Hoofdauteurs: Choi, Min-Joo, Kang, Shin-On, Oh, Jin-Jeong, Park, Seong-Beom, Kim, Min-Ja, Cheong, Hee-Jin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2018
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149703/
https://ncbi.nlm.nih.gov/pubmed/29953307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1456602
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items